Gene · 7472
Papers3,221
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,221
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38185705 | PubTator, text mining | PubMed |
| Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models. | Fitoterapia | 2024 | 38158162 | PubTator, text mining | PubMed |
| Compartmentalization, cooperation, and communication: The 3Cs of Hepatocyte zonation. | Curr Opin Cell Biol | 2024 | 38064779 | PubTator, text mining | PubMed |
| Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs. | Microbiol Spectr | 2024 | 38009950 | PubTator, text mining | PubMed |
| WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway. | Stem Cell Rev Rep | 2024 | 37804416 | PubTator, text mining | PubMed |
| Mechanisms controlling cellular and systemic iron homeostasis. | Nat Rev Mol Cell Biol | 2024 | 37783783 | PubTator, text mining | PubMed |
| Iron regulatory protein 1: the deadly switch of ferroptosis. | Neural Regen Res | 2024 | 37721261 | PubTator, text mining | PubMed |
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| Aloe-emodin exhibits growth-suppressive effects on androgen-independent human prostate cancer DU145 cells via inhibiting the Wnt/β-catenin signaling pathway: an in vitro and in silico study. | Front Pharmacol | 2023 | 38348349 | PubTator, text mining | PubMed |
| Sesquiterpenes and Sesquiterpene Derivatives from Ferula: Their Chemical Structures, Biosynthetic Pathways, and Biological Properties. | Antioxidants (Basel) | 2023 | 38275627 | PubTator, text mining | PubMed |
| Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury. | Front Endocrinol (Lausanne) | 2023 | 38260142 | PubTator, text mining | PubMed |
| Biallelic SOX8 Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction. | Neurol Genet | 2023 | 38235364 | PubTator, text mining | PubMed |
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| A bibliometric and visual analysis of cancer-associated fibroblasts. | Front Immunol | 2023 | 38173726 | PubTator, text mining | PubMed |
| CRNDE: A Pivotal Oncogenic Long Non-Coding RNA in Cancers. | Yale J Biol Med | 2023 | 38161583 | PubTator, text mining | PubMed |
| Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation. | Int J Mol Sci | 2023 | 38139379 | PubTator, text mining | PubMed |
| Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics. | Cancers (Basel) | 2023 | 38136392 | PubTator, text mining | PubMed |
| Aging and Metabolic Reprogramming of Adipose-Derived Stem Cells Affect Molecular Mechanisms Related to Cardiovascular Diseases. | Cells | 2023 | 38132104 | PubTator, text mining | PubMed |
Competing endogenous RNA network analysis of Turner syndrome patient-specific iPSC-derived cardiomyocytes reveals dysregulation of autosomal heart development genes by altered dosages of X-inactivation escaping non-coding RNAs. | Stem Cell Res Ther | 2023 | 38124119 | PubTator, text mining | PubMed |
| Hepcidin and erythroferrone response to 3 weeks of exposure to normobaric hypoxia at rest in trained cyclists. | Front Physiol | 2023 | 38089475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7472/papers?page=8